Company Overview

Update
Headquarters:
London
Funding:
$3.90M
Categories:
Biotechnology

Glythera is a biotechnology company creating a new generation of biological therapeutics through advanced glycosylation technologies.

Description

Update

Creating a new generation of biological therapeutics through advanced glycosylation technologies

Glythera Limited is a young spin-out biotechnology company from the University of Bath with core expertise in protein/peptide functionalisation and glycosylation technologies, imparting improved pharmacokinetic properties to biological therapeutics.

Glythera successfully raised its first round of investment in 2008, with research operations being conducted in dedicated laboratories situated on the campus of the University of Bath

Current Team (1)

Update

Funding Rounds (2) - $3.90M

Update

Investors (1)

Update
  • 0239a5b4576403656e07cb81efeb9c78

    IP Group Plc

    IP Group's core business is the creation of value for its shareholders and partners through..

Offices/Locations (1)

Update
  • Office

    24 Cornhill

    London, EC3V 3ND

    GBR